Remarkable micro-endemism and high congeneric richness: eight new cave-restricted species of Pseudochthonius Balzan, 1892 (Pseudoscorpiones, Chthoniidae) from the Brazilian semi-arid

Posted by
  Remarkable micro-endemism and high congeneric richness: eight new cave-restricted species of Pseudochthonius Balzan, 1892 (Pseudoscorpiones, Chthoniidae) from the Brazilian semi-arid Abstract Eight new species of pseudoscorpions belonging to the genus Pseudochthonius Balzan, 1892 are described from the semi-arid region of Brazil. Comprehensive morphological descriptions, diagnostic characters, detailed illustrations, and ecological remarks of the habitats are provided for Pseudochthonius celestialis sp. nov., P. caritas sp. nov., P. patientia sp. nov., P. temperantia sp. nov., P. diligentia sp. nov., P. castitas sp. nov., P. humilitas sp. nov., and P. benignitas sp. nov. In addition, we present a brief discussion of the potential factors underlying the remarkable congeneric species richness observed in this geographically restricted region, as well as the principal threats faced by these species. These findings underscore the importance of conserving caves in order to pr...

Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090

Posted by

 


Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090

Abstract

HP1090 is a short, cationic, amphipathic peptide derived from scorpion venom and previously described as a membrane-active antiviral compound. Here, we primarily characterize the antiviral activity of HP1090 and assess whether additional antibacterial effects are consistent with membrane-disruptive properties. Chemically synthesized HP1090 exhibited dose-dependent virucidal activity against multiple enveloped viruses, including herpes simplex virus type 1 and 2 (HSV-1, HSV-2), human immunodeficiency virus type 1 (HIV-1), and Zika virus (ZIKV), with IC50 values ranging from 14.7 to 56.1 µg/mL. No activity was observed against the non-enveloped human rhinovirus 14 (HRV14), suggesting strict dependence on a viral lipid envelope. Consistent with a membrane-targeting mechanism, HP1090 induced rapid and concentration-dependent permeabilization of virus-like liposomes. HP1090 also displayed antibacterial activity against selected clinically relevant pathogens in agar-based growth inhibition assays. However, antibacterial effects required substantially higher concentrations (>125 µg/mL) and varied between bacterial species, with some strains showing little or no susceptibility. Membrane permeabilization assays in Listeria monocytogenes demonstrated disruption of bacterial membrane integrity as a contributing mechanism. No cytotoxicity was observed on mammalian cell lines at effective antiviral concentrations. Together, these findings establish HP1090 as a membrane-active venom peptide and, by linking envelope-dependent viral inactivation with bacterial membrane permeabilization, support a shared biophysical mode of action relevant to the development of membrane-targeting anti-infectives.

Asuzano, A. J., Olari, L. R., Jaber, N., Vogel, V., Fam, M. S., Rodríguez Alfonso, A. A., Preising, N., Ständker, L., Spellerberg, B., Breitinger, H. G., Breitinger, U., & Münch, J. (2026). Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090. Toxins. https://doi.org/10.3390/toxins18060268